PT Darya-Varia Laboratoria Tbk (IDX:DVLA)

Indonesia flag Indonesia · Delayed Price · Currency is IDR
1,585.00
-10.00 (-0.63%)
May 29, 2026, 4:04 PM WIB
Market Cap1.78T +5.3%
Revenue (ttm)2.28T +8.7%
Net Income140.39B -16.2%
EPS125.35 -16.2%
Shares Out 1.12B
PE Ratio12.64
Forward PEn/a
Dividend108.00 (6.81%)
Ex-Dividend Daten/a
Volume14,000
Open1,595.00
Previous Close1,595.00
Day's Range1,580.00 - 1,595.00
52-Week Range1,525.00 - 1,740.00
Beta-0.11
Analystsn/a
Price Targetn/a
Earnings DateJul 28, 2026

About IDX:DVLA

PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Consumer Health Products, Prescription Drugs, Export & Toll Manufacturing, and Services. The company offers consumer health products, including skin nutrition products under the Natur-E brand; respiratory products under the Decolgen, ALLERIN EXPECTORANT, Decolsin, NEOZEP, STOP COLD, SILEX, and HERBABLEND brands for nasal congestion, cough, and breathing issues caused by allergy; multivitamins under the Enervon... [Read more]

Sector Healthcare
Founded 1976
Employees 1,351
Stock Exchange Indonesia Stock Exchange
Ticker Symbol DVLA
Full Company Profile

Financial Performance

In 2025, IDX:DVLA's revenue was 2.23 trillion, an increase of 6.90% compared to the previous year's 2.09 trillion. Earnings were 163.95 billion, an increase of 5.00%.

Financial Statements